for mobile/tablet users, please navigate using the menu located below.
  “I took the [road] less traveled by, and that has made all the difference”
~Robert Frost

Let's start working together…

Please send all inquiries to our global coordinator:
Ms. Cate Cebass
Ccebass@technomarkls.com

Philadelphia Office
139 East Lancaster Avenue
Suite 33
Wayne, PA 19087
+1 215 717 7296
London Office
Crown House, 72 Hammersmith Road
London, W14 8TH
+44 (0) 20 7097 1546
 
 
Investment Summary
Industry sector:   Therapeutics, biotech, start-up, med device/diagnostic, med-tech, small/specialty pharma
Size of investment:   30-70% cost of the development studies
Investment stage:   Preclinical, IND-enabling, tox, Phase I-III
Return on investment:   Equity, downstream royalties, milestone payments, etc.
Geography:   Primarily US, UK and rest of EU, Israel